A
The startup develops oncology therapeutics by utilizing a platform that extracts functional p53 proteins from animal tissues, which are known to inhibit cancer cell proliferation. This approach aims to enhance the efficacy of cancer treatments by applying the tumor-suppressing properties of p53 throughout the human body.
Updated 3 months ago
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops oncology therapeutics by utilizing a platform that extracts functional p53 proteins from animal tissues, which are known to inhibit cancer cell proliferation. This approach aims to enhance the efficacy of cancer treatments by applying the tumor-suppressing properties of p53 throughout the human body.